180 related articles for article (PubMed ID: 36319797)
21. A pathological scoring system to predict renal outcome in diabetic nephropathy.
Hoshino J; Mise K; Ueno T; Imafuku A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Hara S; Fujii T; Ohashi K; Ubara Y; Takaichi K
Am J Nephrol; 2015; 41(4-5):337-44. PubMed ID: 26067713
[TBL] [Abstract][Full Text] [Related]
22. The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus.
Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
Ren Fail; 2018 Nov; 40(1):590-596. PubMed ID: 30371119
[TBL] [Abstract][Full Text] [Related]
23. Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.
Chen HY; Pan HC; Chen YC; Chen YC; Lin YH; Yang SH; Chen JL; Wu HT
BMC Complement Altern Med; 2019 Apr; 19(1):81. PubMed ID: 30943956
[TBL] [Abstract][Full Text] [Related]
24. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
[TBL] [Abstract][Full Text] [Related]
25. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
[TBL] [Abstract][Full Text] [Related]
26. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
27. THE ASSOCIATION OF SERUM BILIRUBIN ON KIDNEY CLINICOPATHOLOGIC FEATURES AND RENAL OUTCOME IN PATIENTS WITH DIABETIC NEPHROPATHY: A BIOPSY-BASED STUDY.
Wu Y; Zhang J; Wang J; Wang Y; Han Q; Li H; Wang T; Liu F
Endocr Pract; 2019 Jun; 25(6):554-561. PubMed ID: 30865534
[No Abstract] [Full Text] [Related]
28. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
Chou YH; Lin WC; Chen YM
Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
[TBL] [Abstract][Full Text] [Related]
30. Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action.
Benlloch S; Moncho F; Górriz JL
Nefrologia (Engl Ed); 2024; 44(2):129-138. PubMed ID: 38565488
[TBL] [Abstract][Full Text] [Related]
31. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
32. Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma.
Chen VL; Yeh ML; Yang JD; Leong J; Huang DQ; Toyoda H; Chen YL; Guy J; Maeda M; Tsai PC; Huang CF; Yasuda S; Le AK; Dang H; Giama NH; Ali HA; Zhang N; Wang X; Jun DW; Tseng CH; Hsu YC; Huang JF; Dai CY; Chuang WL; Zhu Q; Dan YY; Schwartz M; Roberts LR; Yu ML; Nguyen MH
Hepatol Commun; 2021 Jan; 5(1):122-132. PubMed ID: 33437906
[TBL] [Abstract][Full Text] [Related]
33. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
[TBL] [Abstract][Full Text] [Related]
34. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
[TBL] [Abstract][Full Text] [Related]
35. Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes.
Byun JM; Lee CH; Lee SR; Moon JY; Lee SH; Lee TW; Ihm CG; Jeong KH
Korean J Intern Med; 2013 Sep; 28(5):565-72. PubMed ID: 24009452
[TBL] [Abstract][Full Text] [Related]
36. Correlation Analysis of Vascular Endothelial Growth Factor Level with Clinicopathological Features and Prognosis in Patients with Diabetic Nephropathy: A Biopsy-based Study.
Zhang J; Zhu H; Tang Q; Wu J
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):192-197. PubMed ID: 37715389
[TBL] [Abstract][Full Text] [Related]
37. Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
Mise K; Yamaguchi Y; Hoshino J; Ueno T; Sekine A; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Sawa N; Fujii T; Hara S; Sugiyama H; Makino H; Wada J; Ohashi K; Takaichi K; Ubara Y
PLoS One; 2017; 12(8):e0183190. PubMed ID: 28813476
[TBL] [Abstract][Full Text] [Related]
38. Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end-stage renal disease.
Zhao L; Zhang J; Lei S; Ren H; Zou Y; Bai L; Zhang R; Xu H; Li L; Zhao Y; Cooper ME; Tong N; Zhang J; Liu F
J Diabetes; 2021 Jul; 13(7):572-584. PubMed ID: 33352010
[TBL] [Abstract][Full Text] [Related]
39. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
40. The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy.
Zhang J; Wang Y; Gurung P; Wang T; Li L; Zhang R; Li H; Guo R; Han Q; Zhang J; Lei S; Liu F
Acta Diabetol; 2018 Jul; 55(7):669-679. PubMed ID: 29610978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
